MARKET

LFSC

LFSC

F/m Emerald Life Sciences Innovation ETF
NASDAQ
44.46
-0.21
-0.47%
After Hours: 44.34 -0.12 -0.28% 19:30 09/25 EDT
OPEN
44.41
PREV CLOSE
44.67
HIGH
44.64
LOW
44.30
VOLUME
3.65K
TURNOVER
--
52 WEEK HIGH
48.78
52 WEEK LOW
29.29
TOTAL ASSET
123.30M
YTD YIELD
54.27%
1D
5D
1M
3M
1Y
5Y
1D
Spyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis Drug
Benzinga · 04/13 17:29
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application
Benzinga · 03/16 16:42
FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer
Benzinga · 01/22 17:51
Travere Stock Slips After FDA Delays Review Of Key Kidney Drug
Benzinga · 01/14 11:44
Best-Performing Active ETFs of 2025
NASDAQ · 12/31/2025 16:00
This New ETF Doesn't Wait For Stability — It Profits From Disruption
Benzinga · 10/14/2025 22:50
Profile
Fund Name
F/m Emerald Life Sciences Innovation ETF
Inception Date
2024-10-30
Benchmark
MSCI ACWI NR USD
Advisor Company
Emerald Mutual Fund Advisers Trust
Custodian
U.S. Bank N.A
Manager
Joseph Garner, Stacey Sears, Nishit Trivedi, Terry M. Smith, Kenneth Mertz